In real-life practice, there are some patients who ask for treatment withdrawal after achieving stable complete remission for a number of reasons including worry regarding adverse events with longterm treatment. The objective of this retrospective study was to investigate psoriasis course (duration of remission and predictors of relapse) in patients who asked to discontinue etanercept after achieving complete and stable remission
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission.
Bellinato, F;Girolomoni, G;Gisondi, P.
2019-01-01
Abstract
In real-life practice, there are some patients who ask for treatment withdrawal after achieving stable complete remission for a number of reasons including worry regarding adverse events with longterm treatment. The objective of this retrospective study was to investigate psoriasis course (duration of remission and predictors of relapse) in patients who asked to discontinue etanercept after achieving complete and stable remission
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
bjd.18225.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Accesso ristretto
Dimensione
196.98 kB
Formato
Adobe PDF
|
196.98 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
